Q: Good Morning,
In light of Friday's announcement of the American Medical Association establishing three "Current Procedural Terminology Category 1 codes for MRI-Monitored Transurethral Ultrasound Ablation ("TULSA") of prostate tissue, performed using Profound's TULSA-PRO system.", can I get your updated opinion on the company? Do you see this as the inflection point patient investors have been waiting for?
My understanding is that Profound's treatment could quickly become the platinum standard for treating BPH and prostate cancer, when private and public health insurers recognize the eventual cost savings due to the high success rate,
Thanks, Brad
In light of Friday's announcement of the American Medical Association establishing three "Current Procedural Terminology Category 1 codes for MRI-Monitored Transurethral Ultrasound Ablation ("TULSA") of prostate tissue, performed using Profound's TULSA-PRO system.", can I get your updated opinion on the company? Do you see this as the inflection point patient investors have been waiting for?
My understanding is that Profound's treatment could quickly become the platinum standard for treating BPH and prostate cancer, when private and public health insurers recognize the eventual cost savings due to the high success rate,
Thanks, Brad